Anne Jones - Nov 16, 2021 Form 4 Insider Report for Celularity Inc (CELU)

Role
Chief Business Officer
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
Stock symbol
CELU
Transactions as of
Nov 16, 2021
Transactions value $
-$7,057
Form type
4
Date filed
11/18/2022, 07:16 PM
Previous filing
Jul 16, 2021
Next filing
Apr 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Award $0 +25K +89.64% $0.00 52.9K Nov 16, 2021 Direct F1, F2
transaction CELU Class A Common Stock Tax liability -$7.06K -3.73K -7.06% $1.89* 49.2K Nov 16, 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
F2 Represents 52,888 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
F3 Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under the 2021 Plan and does not represent a sale.
F4 Includes 40,388 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.